Prognosis: Losing it

At Bloomberg, we’re always talking about the biggest business stories, and no one is bigger than Elon Musk. In this new chat weekly show, host David Papadopoulos and a panel of guests including Businessweek’s Max Chafkin, Tesla reporter Dana Hull, Big Tech editor Sarah Frier, and more, will break down the most important stories on Musk and his empire. Listen wherever you get your podcasts. See omnystudio.com/listener for privacy information.

Smoke Screen: Deadly Cure is a podcast about a family on the fringe who convinced tens of thousands of people across the globe to buy a miracle liquid made of poison, the international conspiracy they ignited, and the people who fought to take them down. Smoke Screen: Deadly Cure is a Neon Hum Media, Bloomberg & Sony Music Entertainment production. See omnystudio.com/listener for privacy information.

Hosted by Bloomberg Opinion senior executive editor Tim O'Brien, Crash Course will bring listeners directly into the arenas where epic business and social upheavals occur. Every week, Crash Course will explore the lessons to be learned when creativity and ambition collide with competition and power -- on Wall Street and Main Street, and in Hollywood and Washington. See omnystudio.com/listener for privacy information.

The battle against humanity’s most challenging diseases is happening at the intersection of business and medicine. A new six-episode podcast called Targeting the Toughest Diseases explores how Vertex Pharmaceuticals, a Boston-based biotech company, is using innovative tools, methods, and a unique philosophy to search for treatments and cures. Produced by Bloomberg Media Studios and Vertex, the podcast’s latest episode features NBA great Alonzo Mourning recounting his fight against kidney disease, and how future generations of patients may have an easier time of it. You can subscribe today on Apple Podcasts, Spotify or wherever you listen to your favorite podcasts. See omnystudio.com/listener for privacy information.

If you’re like many people, there’s a good chance that your weight and calorie considerations play a big role in food decisions. Intuitive eating, an Internet-famous movement all about healing people’s relationships with food, says it shouldn’t be that way. The final episode of “Losing It” explores what it means to eat intuitively, and asks the question: Does it work? See omnystudio.com/listener for privacy information.

What if the dangers of being heavy have been overstated, or misrepresented? This new episode of the podcast series “Losing It” explores the relationship between health and weight, and the argument that we focus on the scale too much and not enough on healthy behaviors. See omnystudio.com/listener for privacy information.

Companies like WW, formerly Weight Watchers, and Noom, which makes a popular weight-loss app, have a new pitch for would-be members: that they can lose weight with a holistic lifestyle approach instead of dieting. This new episode of podcast series “Losing It” explores why the backlash against dieting is happening, how companies are getting in on the action, and whether we're actually over dieting and losing weight. See omnystudio.com/listener for privacy information.

We all think we know the basics of weight loss. It is all about consuming fewer calories than you burn. Eat less, move more. Calories in, calories out. But there’s much more to it than these simple equations, as a trip to the enormous Pennington Biomedical Research Center in Baton Rouge, Louisiana - a hub of such research - shows. In this episode, we break down the science of why it’s so hard to lose weight, and look at what the kinds of stories heralded as a weight-loss success really look like in practice. See omnystudio.com/listener for privacy information.

The South Beach Diet became an incredible success in the early 2000s, blowing past booksellers’ expectations, dominating the cultural moment and becoming a huge business. In the third episode of Losing It, we fly down to glamorous Miami to tell the story of the South Beach Diet and break down the formula for a hit diet. See omnystudio.com/listener for privacy information.

When it comes to dieting, what’s old is new again. In the second episode of Losing we take a trip back in time through diet history — and explore why we keep falling for these absurd-sounding regimens decade after decade. See omnystudio.com/listener for privacy information.

Calorie counts are everywhere from food packages to weight-loss apps. But calories aren’t all that they appear to be. In the series premiere of Losing it, we dive into how we got the calorie so wrong – and pretty much everything else about weight. See omnystudio.com/listener for privacy information.

For much of human history, we’ve turned to diets to lose weight and improve our health. But it’s mostly been in vain. Because no matter how much the number on the scale drops, chances are the weight will come back. That’s just what the science says. But when it comes to our weight, the facts don’t seem to make much difference. Dieting still has a grip on all of us. Losing It, a new series from Bloomberg’s Prognosis, investigates how we got weight loss so wrong — and whether there’s a better way forward. Losing It launches on July 12. Subscribe to Prognosis today on Apple Podcasts, Spotify or wherever you get your favorite podcasts. See omnystudio.com/listener for privacy information.

That's right! We're honored to be nominated for a Webby, in the Science & Education category. Please take a minute to vote for us here: https://vote.webbyawards.com/PublicVoting#/2022/podcasts/general-series/science-education See omnystudio.com/listener for privacy information.

Virus hunters around the globe are already bracing for the next contagion which they fear could prove even more destructive than Covid. These scientists and doctors, drawing from hard-learned lessons from the past, are determined to stop future pandemics even as the current one continues to rage. See omnystudio.com/listener for privacy information.

Covid-19 is just the beginning for messenger RNA vaccines. Researchers are testing shots across a range of diseases, from cancer to malaria, HIV or even multiple sclerosis. There’s no guarantee the technology will work beyond infectious diseases, but if it does, it could transform medicine. See omnystudio.com/listener for privacy information.

Two biotech companies, Germany’s BioNTech and the U.S.’s Moderna, decided in January 2020 to wager their futures on developing a messenger RNA shot to fight Covid-19. What ensued was a head-spinning race to bring a vaccine to market quicker than ever before. See omnystudio.com/listener for privacy information.

The messenger RNA vaccines against Covid-19 seem to have emerged out of nowhere. But they’re based on decades of painstaking work, done in relative obscurity, by researchers who believed in the promise of the technology even if few others did. See omnystudio.com/listener for privacy information.

On the outside, city hospitals look just as they always have: big glass and steel buildings, an ER entrance with ambulances coming and going. But on the inside, Covid has completely transformed the hospital experience for patients, their families -- and for doctors and hospital staff. Once held in high esteem as the place where doctors performed miracles, hospitals have become more sombre places under the staggering weight of illness and death even as communities increasingly view them through the lens of vaccine misinformation and mistrust. See omnystudio.com/listener for privacy information.

The loss of the sense of smell affects almost one in every two people who get Covid-19. Usually it resolves within a week or two. But for some, like Dr. Alex McCutchan, smell and taste distortions persist for a year, leaving an invisible illness that disrupts daily life. Scientists like Leah Beauchamp are learning that its significance doesn’t end there. In this episode, Bloomberg’s Jason Gale meets two best friends who are exploring long Covid’s potentially scary, lifelong consequences. Story has been updated to correct Alex McCutchan's name. See omnystudio.com/listener for privacy information.

Neuroscientist David Putrino doesn’t profess to understand why some Covid-19 survivors suffer persistent symptoms or how to cure them, but he’s finding ways to help “long haulers” take control of their symptoms. In this episode, Bloomberg’s Jason Gale takes a virtual tour of Putrino’s Manhattan long Covid rehab clinic to chronicle patients’ journey to recovery. See omnystudio.com/listener for privacy information.